Ladder Capital Corp
Change company Symbol lookup
Select an option...
LADR Ladder Capital Corp
NEMD iNeedMD Holdings Inc
CVS CVS Health Corp
CMI Cummins Inc
INVH Invitation Homes Inc
OII Oceaneering International Inc
SINO Sino-Global Shipping America Ltd
MLM Martin Marietta Materials Inc
KO Coca-Cola Co
VICI VICI Properties Inc
Go

Financials : Mortgage Real Estate Investment Trusts (REITs) | Small Cap Value
Company profile

Ladder Capital Corp is a commercial real estate finance company. The Company's segments include loans, securities, real estate and corporate/other. The loans segment includes mortgage loan receivables held for investment (balance sheet loans) and mortgage loan receivables held for sale (conduit loans). The securities segment consists of all of its activities related to commercial real estate securities, which include investments in commercial mortgage-backed securities (CMBS) and United States Agency Securities. The real estate segment includes net leased properties, office buildings, a warehouse and condominium units. The Corporate/other segment includes the Company's investments in joint ventures, other asset management activities and operating expenses. The Company invests primarily in loans, securities and other interests in the United States commercial real estate, with a focus on senior secured assets.

Closing Price
$7.50
Day's Change
0.10 (1.35%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.58
Day's Low
7.29
Volume
(Heavy Day)
Volume:
1,591,881

10-day average volume:
934,402
1,591,881

Exclusive Set Of Companies Make Up Majority Of The Global Medication Adherence Market

11:00 am ET August 20, 2020 (Globe Newswire) Print

According to The Business Research Company's research report, the global medication adherence market is concentrated, with a few large players holding a significant portion of the market share, while there is a smaller presence of minor players in the market. The top ten competitors in the market made up 60% of the total market in 2019. Major players in the market include Omnicell Inc., Koninklijke Philips N.V., Cardinal Health, McKesson Corporation, and Allscripts Healthcare Solutions, Inc.

Some major players are undertaking strategic initiatives such as partnerships and business expansions in untapped regions, which is likely to be a major trend in the medication adherence market. For instance, in October 2019, Royal Philips and Spencer Health Solutions expanded their partnership and announced the launch of in-home medication adherence & telehealth platform in Europe. The collaboration aimed at a successful partnership for providing medication adherence solutions to high-acuity patients in the USA and Europe. Beginning with Netherlands in the fourth quarter of 2019, Spencer Smart Hub is launching in selected markets such as Austria, Belgium, Germany, Luxembourg and Switzerland in Europe.

The Business Research Company's report titled Medication Adherence Market Global Report 2020-30: COVID-19 Growth And Change covers major medication adherence companies, medication adherence market share by company, medication adherence manufacturers, medication adherence infrastructure market size, and medication adherence market forecasts. The report also covers the global medication adherence market and its segments. The medication adherence market is segmented by type into hardware centric, software centric, and by medication into cardiovascular, central nervous system, diabetes, oncology, respiratory, gastrointestinal, rheumatology, others.

Request A Free Sample Of The Global Medication Adherence Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3276&type=smp

The medication adherence market report states that the growth in the historic period resulted from rapid growth in elderly population, strong economic growth in emerging markets, rise in healthcare expenditure, and rise in usage of pharmaceuticals. Going forward, increasing prevalence of chronic diseases, increasing adoption of smartphones, increasing demand for personalized healthcare technologies, and advances in medicine will drive the growth of the medical adherence market.

Amidst the unprecedented outbreak of the coronavirus, governments across the world are advising people to stay indoors and practice social distancing to reduce the spread of the disease. This has decreased short-term potential growth opportunities for the medication adherence industry. Healthcare systems in low-and middle-income countries are especially challenged because the pandemic will further crumble the already weak health systems in these countries. These health systems are working with several constraints such as limited financial resources, inadequate health personnel, and unavailability of medications, which is negatively impacting the country's medication adherence market.

To overcome these problems, retail and community pharmacists are working to manage chronic conditions and promote medication adherence during such difficult times by increasing its accessibility. Since the beginning of the COVID-19 pandemic, there has been ample communication encouraging consumers to fill prescriptions early or in larger quantities in order to limit trips to pharmacies. Despite this, the role of community pharmacists during the coronavirus pandemic is gaining importance in the medication adherence market. Community pharmacists are helping patients with chronic diseases by supporting rational medicines use, promoting medication adherence, medication reviews and follow-ups, maintaining chronic diseases' medication availability, triaging at the community level for suspected COVID-19 cases, and spreading information and communication about the coronavirus disease. Some pharmacists are also adopting technological methods to remind patients to take their medicines, such as phone calls, SMS text messaging, and some even use social media platforms. In some instances, courier services are being used for doorstep deliveries of essential medicines and prescription refills, but in such instances, strict consideration for all anti-COVID safety protocols are being adhered to.

Thus, taking the drivers and restraints into account as well, the global medication adherence market size is expected to decline from $2,529.6 million in 2019 to $2,482.3 million in 2020 at a rate of -1.9% due to the lockdown and social distancing norms owing to the COVID-19 outbreak. The market is then expected to recover and grow at a CAGR of 12.5% from 2021 ad reach $3,579.7 million in 2023. It is expected to reach $4,381.0 million in 2025, and $7,277.4 million in 2030.

Medication Adherence Market Global Report 2020-30: COVID-19 Growth And Change is one of a series of new reports from The Business Research Company that provide market overviews, analyze and forecast market size and growth for the whole market, segments and geographies, trends, drivers, restraints, leading competitors' revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies. The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors' approaches.

Here Is A List Of Similar Reports By The Business Research Company:

Pharmacies And Drug Stores Global Market Report 2020-30: COVID-19 Implications and Growth

Healthcare E-Commerce Global Market Report 2020-30: COVID-19 Implications and Growth

Pharmaceuticals Market - Report Segmented By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Type Of Biologics Drugs (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines), And By Region, Opportunities And Strategies - Global Forecast To 2030

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

https://ml.globenewswire.com/media/3bf07720-8041-4b6e-84f3-8c3f28854315/small/the-business-research-company-horizontal-logo-2-png.png

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.